Antibacterial Drugs: Sulfonamides

Slides:



Advertisements
Similar presentations
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Advertisements

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introductory Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
SULFONAMIDES Sulfonamides introduced in 1930s.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere.
Sulfonamides, trimethoprim and Quinolones
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Background Collection of S & O Information Data: – CC, HPI, PMH, PSHx, Demographics – Medication history including compliance etc. – VS, ROS, Lab, other.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 87 Sulfonamides and Trimethoprim.
Quinolones Folic Acid Antagonists Urinary Tract Antiseptics.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Urinary Antiseptics. Organisms  Escherichia coli  Proteus  Pseudomonas species  streptococci  Klebsiella  Enterococcus  Staphylococcus epidermidis.
Drugs Used to Treat Disorders of the Urinary System Chapter 42 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Dr. Steven I. Dworkin Drugs for the Treatment of Infections Bacteria, Fungi, and Viruses.
 The ARBs include the following drugs:  azilsartan (Edarbi),candesartan (Atacand), eprosartan (Teveten), irbesartan(Avapro), losartan (Cozaar), olmesartan.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Antimicrobials - Sulfonamides Antimicrobials - Sulfonamides Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy College Pharmacy College 1.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Chapter 30 Drugs used to treat urinary system disorders
Chapter 13 Pain Management.
Focus on Pharmacology Essentials for Health Professionals
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA
Urinary System Function, Assessment, and Therapeutic Measures
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 15 Opioid Analgesics
Posterior pituitary hormones: Vasopressin
Other Protein Synthesis Inhibitor
Sulfonamides صيدلانية نظري / د . فارس رابع صيدلة 23 / 4 / 2016
Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs
Introduction to Sulfonamides
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Chapter 33 Acute Care.
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 42 Antidiabetic Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Synthetic antimicrobial drugs
Lower Urinary Tract Problems
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Introduction to Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Cholinesterase Inhibitors: Actions and Uses
Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates
Introduction to Sedatives and Hypnotics #1
Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Antibacterial Drugs: Sulfonamides Chapter 6 Antibacterial Drugs: Sulfonamides

Introduction to Sulfonamides Effective antibiotic drugs against infections Antibacterial agent: bacteriostatic (slow growing): active against bacteria

Actions and Uses Inhibit the activity of folic acid in bacterial cell metabolism Bacteriostatic-slow the rate of bacterial multiplication Able to be excreted by kidneys

Uses Control urinary tract infections caused by both gram-negative and gram-positive bacteria UTIs, acute otitis media, ulcerative colitis Escherichia coli, Staphylococcus aureus, and Klebsiella and Enterobacter species Treat infections caused by second- and third- degree burns

Adverse Reactions #1 Common reactions: anorexia, nausea, vomiting, diarrhea, abdominal pain, chills, fever, stomatitis Urine and skin take on an orange-yellow color: this is not abnormal Crystalluria: increase fluid intake Photosensitivity: wear protective clothing or sunscreen

Adverse Reactions #2 Hypersensitivity reactions: Pruritus (itching) Urticaria (hives) Generalized skin eruptions Severe reactions leading to potentially lethal conditions such as toxic epidermal necrolysis or Stevens--Johnson syndrome

Nursing Alert: TEN and Stevens–Johnson Syndrome Be alert for the additional signs of lesions Notify primary health care provider and withhold next dose Exercise care to prevent injury Observe for hematologic changes during prolonged sulfonamide therapy Thrombocytopenia; aplastic anemia; leukopenia

Contraindications and Precautions Patients with hypersensitivity to sulfonamides During lactation; near the end of pregnancy; in children younger than 2 years old Infections caused by group A beta-hemolytic streptococci Use cautiously for renal impairment, hepatic impairment, and bronchial asthma

Interactions Interactant Drug Effect of Interaction Oral anticoagulants Increased action of the anticoagulant Methotrexate (Rheumatrex) Increased bone marrow suppression Hydantoins (e.g., phenytoin [Dilantin]) Increased serum hydantoin level

Chronic Care and Health Supplement Alert Diabetic patients: assess for hypoglycemic reaction-especially if taking tolbutamide and chlorpropamide Cranberries/cranberry juice: prevents and relieves symptoms of UTIs Combination of cranberries with antibiotics: long- term suppression of UTIs Extremely large doses of cranberries: produce gastrointestinal disturbances

Nursing Process: The Patient Receiving a Sulfonamide #1 Preadministration assessment Assess patient’s general appearance, general health history, allergies; take and record the vital signs Obtain information: symptoms experienced by patient and duration of symptoms; use of self- remedies such as supplement, herbs, etc Review results of tests-what tests in specific?

Nursing Process: The Patient Receiving a Sulfonamide #2 Ongoing assessment Evaluate at periodic intervals: relief of symptoms, decrease in temperature, occurrence of adverse reactions Monitor temperature, pulse, respiratory rate, blood pressure Observe for relief/intensification of symptoms Report adverse reactions Monitor bowel stools for number, appearance, possible blood or tarry stools

Nursing Process: The Patient Receiving a Sulfonamide #3 Nursing diagnoses Impaired Urinary Elimination—related to effect on the bladder from the sulfonamides Impaired Skin Integrity—related to burns, photosensitivity, or severe allergic reaction to the sulfonamides Risk for Secondary Infection—related to lowered white blood cell count resulting from sulfonamide therapy

Nursing Process: The Patient Receiving a Sulfonamide #4 Planning Expected patient outcomes depend on the reason for administration of the sulfonamide but may include: An optimal response to drug therapy Management of adverse drug reactions An understanding of and compliance with the prescribed treatment regimen

Nursing Process: The Patient Receiving a Sulfonamide #5 Implementation Dosage: empty stomach—1 hour before or 2 hours after meals; have patient sitting up lessen GI disturbances Exception: primary health care provider's orders Gastrointestinal irritation: give sulfasalazine with food or immediately after meals; drink at least eight large glasses of water each day

Impaired Urinary Elimination Adverse effect of sulfonamide drug: altered elimination patterns Help patient maintain adequate fluid intake and output: prevent crystalluria and stone (calculi) formation in genitourinary tract Patient's intake and output: measure and record every 8 hours Notify primary health care provider: urinary output decreases or the patient fails to increase his or her oral intake

Gerontologic Alert Renal impairment: common in older adults— administer sulfonamides with great caution Renal impairment already present: increased danger of the sulfonamides causing additional renal damage Increase fluid intake up to 2000 mL: decreased risk of crystal and stone formation in urinary tract Patient hesitant to increase oral fluid intake—fear of incontinence: assess for this fear; teach about when can increase fluids

Impaired Skin Integrity: Burn Injury Mafenide or silver sulfadiazine: used in treating burns—treatment regimen outlined by the primary health care provider or the personnel in the burn treatment unit Burn treatment regimens: debridement, special dressings, and cleansing of the burned area Treatment regimen depends on extent of the burned area, degree of the burns, physical condition, and age of the patient

Treatment: Burn Injury When instructed: clean and removes debris from surface of the skin; apply mafenide or silver sulfadiazine with a sterile gloved hand Drug applied approximately 1/16 in thick Keep patient away from draft of air as slightest movement of air across the burned area can cause pain Warn patient: stinging or burning during and for a short time after application of mafenide; burning also noted with silver sulfadiazine

Impaired Skin Integrity: Photosensitivity Skin: more sensitive to sunlight when taking sulfonamides Sunscreens recommended: should not be used in place of protective clothing Inspect skin for signs of sores or blisters Skin and mucous membranes: inspect for up to 14 days

Risk for Secondary Infection Leukopenia: signs and symptoms of an infection, such as fever, sore throat, and cough Thrombocytopenia: easy bruising and unusual bleeding after moderate to slight trauma to the skin Encourage patient to use a soft-bristled toothbrush Report signs of thrombocytopenia immediately: indication to stop drug therapy

Educating the Patient and Family Emphasize the importance of completing the prescribed course-need to maintain drug levels Develop a teaching plan to include: Keep all follow-up appointments Drink at least eight to ten 8-ounce glasses of fluid every day When going outside, cover exposed areas of the skin or apply a protective sunscreen to exposed areas

Evaluation #1 The therapeutic drug effect is achieved No evidence of infection The patient’s fluid intake is at least 2000 milliliters and output is at least 1200 milliliters daily while taking a sulfonamide The skin is intact and free of inflammation, irritation, or ulcerations

Evaluation #2 Adverse reactions are identified, reported to the primary health care provider, and managed successfully through appropriate nursing interventions The patient verbalizes the importance of complying with the prescribed treatment regimen The patient and family demonstrate an understanding of the drug regimen